Fluconazole decreases cyclosporine dosage in renal transplanted dogs

Research in Veterinary Science

Volumn 89, Issue 1, 2010, Pages 124-125

  Katayama, Masaaki ^a,b   Igarashi, Hiroyuki ^a   Fukai, Kazuhiro ^a   Tani, Kenji ^c   Momota, Yutaka ^d   Kamishina, Hiroaki ^a   Tagawa, Masahiro ^b  

^a IWATE UNIVERSITY   (Japan)

^b Nippon Veterinary and Life Science University   (Japan)

^c YAMAGUCHI UNIVERSITY   (Japan)

^d NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

Cyclosporine; Dog; Fluconazole; Immunosuppressive therapy; Renal transplantation

Indexed keywords

CICPORAL; CYCLOSPORIN; FLUCONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CROSS REACTIVITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; EXPERIMENTAL DOG; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; TREATMENT DURATION;

ANIMALS; ANTIFUNGAL AGENTS; CYCLOSPORINE; DOGS; DRUG INTERACTIONS; FEMALE; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE;

CANIS FAMILIARIS;

EID: 77952885812     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2009.12.018     Document Type: Article

References (8)

1. Canafax D.M., Graves N.M., Hilligoss D.M., Carleton B.C., Gardner M.J., Matas A.J. Interaction between cyclosporine and fluconazole in renal allograft recipients. Transplantation 1991, 51:1014-1018.
2. D'Mello A., Venkataramanan R., Satake M., Todo S., Takaya S., Ptachcinski R.J., Burckart G.J., Starzl T.E. Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs. Research Communications in Chemical Pathology and Pharmacology 1989, 64:441-454.
3. Dahlinger J., Gregory C., Bea J. Effect of ketoconazole on cyclosporine dose in healthy dogs. Veterinary Surgery 1998, 27:64-68.
4. Gregory C.R., Kyles A.E., Bernsteen L., Mehl M. Results of clinical renal transplantation in 15 dogs using triple drug immunosuppressive therapy. Veterinary Surgery 2006, 35:105-112.
5. Kageyama M., Namiki H., Fukushima H., Ito Y., Shibata N., Takada K. In vivo effects of cyclosporin A and ketoconazole on the pharmacokinetics of representative substrates for P-glycoprotein and cytochrome P450 (CYP) 3A in rats. Biological and Pharmaceutical Bulletin 2005, 28:316-322.
6. Katayama M., Igarashi H., Tani K., Nezu Y., Harada Y., Yogo T., Hara Y., Aoki S., Tagawa M. Effect of multiple oral dosing of fluconazole on the pharmacokinetics of cyclosporine in healthy beagles. The Journal of Veterinary Medical Science/The Japanese Society of Veterinary Science 2008, 70:85-88.
7. Pape L., Froede K., Strehlau J., Ehrich J.H., Offner G. Alterations of cyclosporin A metabolism induced by mycophenolate mofetil. Pediatric Transplantation 2003, 7:302-304.
8. Steffan J., Strehlau G., Maurer M., Rohlfs A. Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs. Journal of Veterinary Pharmacology and Therapeutics 2004, 27:231-238.